Published in Digestion on January 01, 1984
The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med (2013) 1.21
Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis. Br J Cancer (1985) 0.93
Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer. Br J Cancer (1989) 0.84
A human genome diversity cell line panel. Science (2002) 14.11
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93
HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A (1993) 2.91
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A (1981) 2.86
NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med (1994) 2.61
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther (2014) 2.27
No standard treatment is available for advanced pancreatic cancer. Eur J Cancer (1995) 2.23
Splenic abscess. Br J Surg (1995) 2.10
Precut papillotomy: primum non nocere. Gastrointest Endosc (1990) 2.07
Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02
Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science (1993) 1.98
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest (2003) 1.86
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol (1993) 1.74
Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg (2000) 1.58
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther (2003) 1.52
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol (1999) 1.50
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Aliment Pharmacol Ther (2004) 1.49
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49
Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics (1980) 1.48
Heterogeneous immunophenotype of granular lymphocyte expansions: differential expression of the CD8 alpha and CD8 beta chains. Blood (1992) 1.45
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? J Clin Gastroenterol (1996) 1.44
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD). Aliment Pharmacol Ther (2003) 1.44
The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. Arthritis Rheum (2002) 1.43
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Dig Liver Dis (2006) 1.42
Vesico-ureteral reflux in pediatric kidney transplants: clinical relevance to graft and patient outcome. Pediatr Transplant (1999) 1.42
H2 antagonist and omeprazole nonresponders. Dig Dis Sci (1991) 1.39
Mitochondrial DNA polymorphism in four Sardinian villages. Ann Hum Genet (1988) 1.39
Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol (1999) 1.39
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1999) 1.38
Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci. J Immunol (1988) 1.26
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis (2006) 1.26
Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases. Gastrointest Endosc (2001) 1.24
Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci (1999) 1.18
24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry. Dig Dis Sci (1988) 1.18
A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res (2009) 1.14
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases. Cancer (1988) 1.13
Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature (1989) 1.13
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.12
Linkage of Chido and HL-A. Tissue Antigens (1974) 1.12
HLA-B locus sequence-based typing. Tissue Antigens (1999) 1.10
Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med (1983) 1.10
The 13C urea breath test in the diagnosis of Helicobacter pylori infection. Gut (1999) 1.10
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. Dig Liver Dis (2005) 1.09
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther (2009) 1.09
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. Aliment Pharmacol Ther (1999) 1.08
Letter: Treatment for small intestinal bacterial overgrowth--where are we now? Aliment Pharmacol Ther (2014) 1.06
Mean and median of pH values, characterizing average intragastric acidity. Am J Gastroenterol (1989) 1.06
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis (2004) 1.06
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc (1996) 1.05
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol (1998) 1.05
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Hepatology (1997) 1.04
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2010) 1.04
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol. Aliment Pharmacol Ther (2009) 1.03
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Aliment Pharmacol Ther (2000) 1.02
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Hepatogastroenterology (2001) 1.00
Bacterial adherence to plastics: a role in endoscope-transmitted infections. Lancet (1984) 0.99
Systemic hemodynamic changes in mansonic schistosomiasis with portal hypertension treated by azygoportal disconnection and splenectomy. Am J Gastroenterol (1999) 0.99
Pyogenic liver abscess: the role of surgical treatment. Int Surg (1997) 0.98
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. Scand J Gastroenterol (1989) 0.98
Acid and gastric metaplasia in the duodenum. Gut (1994) 0.98
Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.98
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97
Age of onset in familial adenomatous polyposis: heterogeneity within families and among APC mutations. Ann Hum Genet (1994) 0.97
HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsiveness. Tissue Antigens (1997) 0.97
A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature (1989) 0.97
Letter: biological therapies are effective for prevention of post-operative Crohn's disease recurrence. Aliment Pharmacol Ther (2014) 0.96
Gastric metaplasia and Helicobacter pylori infection. Gut (1995) 0.96
HLA-DR typing by radioimmunoassay. Transplantation (1980) 0.96
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil (2013) 0.94
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones. Clin Exp Immunol (2001) 0.94
The clinical significance of gastric epithelial dysplasia. Endoscopy (1986) 0.94
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol (2000) 0.93
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil (2010) 0.92
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. Fam Cancer (2012) 0.92
Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. Dig Dis Sci (1994) 0.92
Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood (1991) 0.92
The distribution of DR5, MT2, and MB3 specificities on human Ia subsets. Immunogenetics (1983) 0.92
Evaluation of cellular immune responses and soluble mediators in patients with chronic hepatitis C virus (cHCV) infection. Immunopharmacol Immunotoxicol (1995) 0.92
[Anorectal malignant melanoma. A case in the anorectal junction synchronous with adenocarcinoma of the sigmoid]. Minerva Chir (1981) 0.91
Identification of new cell surface markers in man: the problem of immunogenicity. Transplant Proc (1979) 0.91
[Hyperdynamic circulation in Manson's hepatosplenic schistosomiasis]. Rev Hosp Clin Fac Med Sao Paulo (1998) 0.91
CA 19-9 assay in patients with extrahepatic cholestatic jaundice. Int J Biol Markers (1989) 0.91
Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Aliment Pharmacol Ther (2003) 0.91
Nutrition and immunity: laboratory and clinical aspects. Curr Pharm Des (2003) 0.91
Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. Eur J Cancer (2003) 0.90